Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1191 Articles

Lee Jackson | Apr 2, 2026 at 8:10 AM EDT

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

With inflation back in the economic picture, simply getting a dependable income stream may not be the best strategy for…

Rich Duprey | Mar 31, 2026 at 11:30 AM EDT

Here’s Why You Don’t Bet Against This Dividend King

Markets have delivered plenty of twists lately, with inflation cooling but growth uneven and volatility still lurking around every earnings…

Michael Williams | Mar 30, 2026 at 9:15 AM EDT

The Low-Volatility Promise of ACWV Costs Investors 118% Over a Decade Compared to SPY

The VIX has climbed 41% in a single month, sitting at 26.95 and in the 93rd percentile of the past…

Michael Williams | Mar 28, 2026 at 7:15 AM EDT

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of…

John Seetoo | Mar 27, 2026 at 11:49 AM EDT

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

Retirees and income-focused investors have long used Vanguard Value ETF (NYSEARCA:VTV) as a core portfolio anchor, drawn to its dividend…

Michael Williams | Mar 26, 2026 at 2:32 PM EDT

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

Healthcare spending doesn’t stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT),…

John Seetoo | Mar 25, 2026 at 1:30 PM EDT

VIG Returned 223% Over 10 Years and Still Costs Almost Nothing

A 1.5% yield sounds unimpressive until you realize the dividend check doubles roughly every seven years. That is the premise…

John Seetoo | Mar 24, 2026 at 10:07 AM EDT

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

Half of every dollar invested in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) rides on just two companies pulling in opposite directions…

Austin Smith | Mar 20, 2026 at 8:02 AM EDT

JP Morgan’s Dividend Leaders ETF Sounds Good, But The Yield Underwhelms

JPMorgan Dividend Leaders ETF (NYSEARCA:JDIV) launched in September 2024 with an appealing premise: a curated portfolio of global dividend leaders.…

Chris MacDonald | Mar 19, 2026 at 2:57 PM EDT

How Much Do you Need To Invest to Make $100k On Dividends Right Now?

Let’s cut through the noise on this dividend dream that keeps investors up at night. The key question many investors have…

Joel South | Mar 17, 2026 at 11:56 AM EDT

Why One Analyst Thinks Johnson & Johnson Reaches $280

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) has been one of healthcare’s standout performers over the past year, with…

Lee Jackson | Mar 13, 2026 at 7:42 AM EDT

The 5 Safest Dividend Kings Are the Only Stocks to Buy Now

The stock market could face serious trouble as 2026 heads into the second quarter under duress. Extreme valuations collide with…

David Beren | Mar 11, 2026 at 8:55 AM EDT

What Happens to Dividend Income When the Next Recession Hits

Recession fears have a way of making income investors second-guess everything, and if dividends are paid out of cash flow,…

Lee Jackson | Mar 11, 2026 at 8:10 AM EDT

Hope for the Best and Plan for the Worst: The 5 Safest Dividend Aristocrats

The stock market could face serious trouble in 2026 as extreme valuations collide with geopolitical tensions, AI investment skepticism, and…

Austin Smith | Mar 11, 2026 at 7:57 AM EDT

ETFs With Yields Above 10% Using Completely Different Strategies

With the federal funds rate sitting at 3.75% and the 10-year Treasury yielding 4.13%, investors hunting for meaningful income have…

1 … 7 8 9 10 11 … 80

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

Here’s Why You Don’t Bet Against This Dividend King

The Low-Volatility Promise of ACWV Costs Investors 118% Over a Decade Compared to SPY

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

VIG Returned 223% Over 10 Years and Still Costs Almost Nothing

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

JP Morgan’s Dividend Leaders ETF Sounds Good, But The Yield Underwhelms

How Much Do you Need To Invest to Make $100k On Dividends Right Now?

Why One Analyst Thinks Johnson & Johnson Reaches $280

The 5 Safest Dividend Kings Are the Only Stocks to Buy Now

What Happens to Dividend Income When the Next Recession Hits

Hope for the Best and Plan for the Worst: The 5 Safest Dividend Aristocrats

ETFs With Yields Above 10% Using Completely Different Strategies

ChatGPT Almost Cost This Guy $50 Million With Incredibly Dumb Advice

The IRMAA Surprise That Costs 401(k) Holders $1,783 a Year in Hidden Medicare Premiums

Apple’s Latest Reveal Proves That Micron Has “More Room To Run”

ChatGPT Almost Cost This Guy $50 Million With Incredibly Dumb Advice

The IRMAA Surprise That Costs 401(k) Holders $1,783 a Year in Hidden Medicare Premiums

ChatGPT Almost Cost This Guy $50 Million With Incredibly Dumb Advice

The IRMAA Surprise That Costs 401(k) Holders $1,783 a Year in Hidden Medicare Premiums

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

Here’s Why You Don’t Bet Against This Dividend King

The Low-Volatility Promise of ACWV Costs Investors 118% Over a Decade Compared to SPY

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

VIG Returned 223% Over 10 Years and Still Costs Almost Nothing

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

JP Morgan’s Dividend Leaders ETF Sounds Good, But The Yield Underwhelms

How Much Do you Need To Invest to Make $100k On Dividends Right Now?

Why One Analyst Thinks Johnson & Johnson Reaches $280

The 5 Safest Dividend Kings Are the Only Stocks to Buy Now

What Happens to Dividend Income When the Next Recession Hits

Hope for the Best and Plan for the Worst: The 5 Safest Dividend Aristocrats

ETFs With Yields Above 10% Using Completely Different Strategies

ChatGPT Almost Cost This Guy $50 Million With Incredibly Dumb Advice

The IRMAA Surprise That Costs 401(k) Holders $1,783 a Year in Hidden Medicare Premiums

Apple’s Latest Reveal Proves That Micron Has “More Room To Run”

Featured Reads

ChatGPT Almost Cost This Guy $50 Million With Incredibly Dumb Advice

The IRMAA Surprise That Costs 401(k) Holders $1,783 a Year in Hidden Medicare Premiums